GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MedMen Enterprises Inc (OTCPK:MMNFQ) » Definitions » ROE % Adjusted to Book Value

MedMen Enterprises (MedMen Enterprises) ROE % Adjusted to Book Value : -493.21% (As of Mar. 2023)


View and export this data going back to 2018. Start your Free Trial

What is MedMen Enterprises ROE % Adjusted to Book Value?

MedMen Enterprises's ROE % for the quarter that ended in Mar. 2023 was -93.71%. MedMen Enterprises's PB Ratio for the quarter that ended in Mar. 2023 was 0.19. MedMen Enterprises's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2023 was -493.21%.


MedMen Enterprises ROE % Adjusted to Book Value Historical Data

The historical data trend for MedMen Enterprises's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMen Enterprises ROE % Adjusted to Book Value Chart

MedMen Enterprises Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -66.50 -21.01 -211.55 -84.06 -231.88

MedMen Enterprises Quarterly Data
Apr18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -60.12 -416.10 33.31 -324.92 -493.21

Competitive Comparison of MedMen Enterprises's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, MedMen Enterprises's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedMen Enterprises's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MedMen Enterprises's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where MedMen Enterprises's ROE % Adjusted to Book Value falls into.



MedMen Enterprises ROE % Adjusted to Book Value Calculation

MedMen Enterprises's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-113.62% / 0.49
=-231.88%

MedMen Enterprises's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-93.71% / 0.19
=-493.21%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedMen Enterprises ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of MedMen Enterprises's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


MedMen Enterprises (MedMen Enterprises) Business Description

Traded in Other Exchanges
Address
10115 Jefferson Boulevard, Culver City, CA, USA, 90232
MedMen Enterprises Inc formerly known as Ladera Ventures Corp is the preeminent cannabis company with multiple assets and operations in California, Nevada, and New York, which combined account for nearly half of North America's addressable legal market. The company owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail.

MedMen Enterprises (MedMen Enterprises) Headlines